Zhang et al. (2009) revealed that high levels of miR-210 in human colon carcinoma cells HCT116 led to increased c-Myc expression through the reduction of MNT, a known MYC antagonist, responsible to impair proproliferative and proapoptotic functions of c-Myc [42]. Here, MYC is linked to colon carcinoma.